Literature DB >> 20004541

Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.

Mario Jug1, Francesca Maestrelli, Marco Bragagni, Paola Mura.   

Abstract

Binary products of bupivacaine hydrochloride (BVP HCl), an amide type local anesthetic, with parent beta-cyclodextrin (beta-CD) and its soluble beta-cyclodextrin-epichlorohydrin polymer (EPI-beta-CD) were prepared and evaluated as a first phase in the development of a novel mucoadhesive formulation aimed for buccal delivery of this drug. The solid products were obtained by physical mixing, ball milling in high-energy mills, co-evaporation and lyophilisation, in order to rationally select the most effective preparation technique. The solid products obtained were carefully characterised by differential scanning calorimetry (DSC), X-ray powder diffractometry (XRPD), Fourier transform infrared spectroscopy (FTIR) and environmental scanning electron microscopy (ESEM). The impact of the preparation techniques on the physicochemical properties of plain drug was also studied. Results of solid-state analysis revealed more intense interactions of BVP HCl with EPI-beta-CD than with native beta-CD, accompanied by stronger reduction of drug crystallinity in the samples, probably favoured by the amorphous nature of the polymeric carrier. While summarising the results of DSC and XRPD analyses, it seems that ball milling of drug/cyclodextrin binary mixtures was particularly efficient in inducing solid-state interaction between the components and it can be considered as the method of choice for preparation of complexes of BVP HCl with beta-CD and EPI-beta-CD. In vitro dissolution properties in artificial saliva of ball-milled BVP HCl and corresponding CD complexes were investigated by simulating the conditions present at the surface of the buccal mucosa. The obtained results confirmed that complexation of BVP HCl with beta-CD and EPI-beta-CD is a suitable tool for properly tailoring the dissolution properties of the drug and it can be favourably exploited for the development of an effective buccal drug delivery system. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004541     DOI: 10.1016/j.jpba.2009.11.013

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  11 in total

Review 1.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

2.  Investigation into spinal anesthetic failure with hyperbaric bupivacaine: the role of cold exposure on bupivacaine degradation.

Authors:  Ellen K Wasan; Calen Sacevich; Anas El-Aneed; Munawar Mohammed; Jaweria Syeda; Erin Neville; Tatiana Orlowski; David Campbell; Jonathan Gamble
Journal:  Can J Anaesth       Date:  2019-03-15       Impact factor: 5.063

3.  Characterization of albendazole-randomly methylated-β-cyclodextrin inclusion complex and in vivo evaluation of its antihelmitic activity in a murine model of Trichinellosis.

Authors:  Agustina García; Darío Leonardi; María D Vasconi; Lucila I Hinrichsen; María C Lamas
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

Review 4.  Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications.

Authors:  Eneko Larrañeta; Sarah Stewart; Michael Ervine; Rehan Al-Kasasbeh; Ryan F Donnelly
Journal:  J Funct Biomater       Date:  2018-01-24

Review 5.  Strategies to Obtain Encapsulation and Controlled Release of Small Hydrophilic Molecules.

Authors:  Qi Li; Xiaosi Li; Chao Zhao
Journal:  Front Bioeng Biotechnol       Date:  2020-05-13

6.  Anisotropic microparticles for differential drug release in nerve block anesthesia.

Authors:  Shivakumar B S; Vignesh Gopalakrishnan-Prema; Gayathri Raju; Sumi E Mathew; Neeraj Katiyar; Deepthy Menon; Sahadev A Shankarappa
Journal:  RSC Adv       Date:  2021-01-22       Impact factor: 3.361

7.  Cyclodextrin Complexation of Fenofibrate by Co-Grinding Method and Monitoring the Process Using Complementary Analytical Tools.

Authors:  Balázs Attila Kondoros; Ottó Berkesi; Zsolt Tóth; Zoltán Aigner; Rita Ambrus; Ildikó Csóka
Journal:  Pharmaceutics       Date:  2022-06-23       Impact factor: 6.525

8.  Increasing the Hydrophobic Component of Poloxamers and the Inclusion of Salt Extend the Release of Bupivacaine from Injectable In Situ Gels, While Common Polymer Additives Have Little Effect.

Authors:  Hani Abdeltawab; Darren Svirskis; Andrew G Hill; Manisha Sharma
Journal:  Gels       Date:  2022-08-02

9.  Raman and Infrared spectroscopies and X-ray diffraction data on bupivacaine and ropivacaine complexed with 2-hydroxypropyl-β-cyclodextrin.

Authors:  Murillo L Martins; Juergen Eckert; Henrik Jacobsen; Everton C Dos Santos; Rosanna Ignazzi; Daniele Ribeiro de Araujo; Marie-Claire Bellissent-Funel; Francesca Natali; Michael Marek Koza; Aleksander Matic; Eneida de Paula; Heloisa N Bordallo
Journal:  Data Brief       Date:  2017-09-04

Review 10.  Grinding as Solvent-Free Green Chemistry Approach for Cyclodextrin Inclusion Complex Preparation in the Solid State.

Authors:  Mario Jug; Paola Angela Mura
Journal:  Pharmaceutics       Date:  2018-10-16       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.